Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pemetrexed”

704 trials

Showing 20 of 704 results

Large-scale testing (Phase 3)Study completedNCT00190762
What this trial is testing

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Who this might be right for
Mesothelioma
Eli Lilly and Company 240
Testing effectiveness (Phase 2)Ended earlyNCT00383266
What this trial is testing

A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Washington University School of Medicine 9
Large-scale testing (Phase 3)Study completedNCT03976323
What this trial is testing

Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

Who this might be right for
Carcinoma, Nonsquamous Non-small-cell Lung
Merck Sharp & Dohme LLC 1,003
Early research (Phase 1)WithdrawnNCT01836341
What this trial is testing

Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation

Who this might be right for
Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00387322
What this trial is testing

Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 42
Testing effectiveness (Phase 2)Looking for participantsNCT06440954
What this trial is testing

Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases

Who this might be right for
Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital 220
Testing effectiveness (Phase 2)Ended earlyNCT00612677
What this trial is testing

Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 1
Not applicableUnknownNCT01343264
What this trial is testing

Trimodality Therapy for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
HSK Wiesbaden 200
Testing effectiveness (Phase 2)Study completedNCT03256136
What this trial is testing

Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC

Who this might be right for
Lung Cancer
Massachusetts General Hospital 9
Testing effectiveness (Phase 2)Study completedNCT01705184
What this trial is testing

Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Intergroupe Francophone de Cancerologie Thoracique 120
Testing effectiveness (Phase 2)UnknownNCT03778138
What this trial is testing

Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC

Who this might be right for
Non-squamous Cell Non-Small Cell Lung Cancer
Henan Provincial People's Hospital 51
Testing effectiveness (Phase 2)Study completedNCT00660816
What this trial is testing

Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 46
Large-scale testing (Phase 3)UnknownNCT03992885
What this trial is testing

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01783834
What this trial is testing

Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients

Who this might be right for
Previous Treated Metastatic Non-small Cell Lung Cancer
Gachon University Gil Medical Center 95
Large-scale testing (Phase 3)UnknownNCT03952403
What this trial is testing

HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
CarcinomaNon-Small-Cell Lung
Shanghai Henlius Biotech 643
Early research (Phase 1)Study completedNCT02639091
What this trial is testing

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

Who this might be right for
Medical Oncology
Bayer 36
Early research (Phase 1)Study completedNCT00573690
What this trial is testing

Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
UNC Lineberger Comprehensive Cancer Center 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT06155279
What this trial is testing

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

Who this might be right for
Pleural Mesothelioma
Istituto Oncologico Veneto IRCCS 41
Large-scale testing (Phase 3)Study completedNCT00440414
What this trial is testing

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 320
Testing effectiveness (Phase 2)Study completedNCT00988858
What this trial is testing

Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 55
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation